Christopher Paul Day
#105,121
Most Influential Person Now
Christopher Paul Day's AcademicInfluence.com Rankings
Christopher Paul Dayphilosophy Degrees
Philosophy
#4223
World Rank
#6666
Historical Rank
Logic
#1728
World Rank
#2563
Historical Rank

Download Badge
Philosophy
Christopher Paul Day's Degrees
- PhD Biomedical Sciences University of California, San Francisco
- Doctorate Medicine University of California, San Francisco
Why Is Christopher Paul Day Influential?
(Suggest an Edit or Addition)Christopher Paul Day's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Steatohepatitis: a tale of two "hits"? (1998) (3951)
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD (2007) (2381)
- EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. (2016) (1859)
- Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. (2010) (1381)
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (2013) (1332)
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications (1999) (1264)
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin (2009) (956)
- The natural history of nonalcoholic fatty liver: A follow‐up study (1995) (939)
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. (2018) (881)
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. (2015) (819)
- Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers (2007) (701)
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease (2010) (689)
- Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease (2010) (573)
- EASL clinical practical guidelines: management of alcoholic liver disease. (2012) (570)
- Non-alcoholic fatty liver disease: the mist gradually clears. (2008) (565)
- Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. (2004) (476)
- TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease (2014) (468)
- Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. (2012) (464)
- Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver (1995) (456)
- Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss (2011) (440)
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis (2016) (426)
- Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. (2011) (421)
- From fat to inflammation. (2006) (420)
- Pathogenesis of steatohepatitis. (2002) (419)
- Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. (2013) (417)
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. (2016) (406)
- The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study (2011) (403)
- Hepatic steatosis: Innocent bystander or guilty party? (1998) (395)
- Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. (2014) (392)
- Nonalcoholic fatty liver disease (2015) (374)
- Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. (1998) (373)
- Elevated endotoxin levels in non-alcoholic fatty liver disease (2010) (333)
- From NAFLD in clinical practice to answers from guidelines. (2013) (332)
- Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score (2005) (326)
- Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. (2007) (319)
- Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease (2010) (296)
- The genetics of NAFLD (2013) (295)
- Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis (1997) (291)
- Standardization of nomenclature and causality assessment in drug‐induced liver injury: Summary of a clinical research workshop (2010) (288)
- Non-alcoholic steatohepatitis: another disease of affluence (1999) (281)
- Prednisolone or pentoxifylline for alcoholic hepatitis. (2015) (277)
- QT prolongation and sudden cardiac death in patients with alcoholic liver disease (1993) (250)
- Benefits of lifestyle modification in NAFLD (2007) (240)
- NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men (2008) (212)
- Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C (1998) (209)
- Non-Alcoholic Fatty Liver Disease in Older People (2009) (208)
- Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity (2004) (203)
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort. (2020) (202)
- Treatment of Non-Alcoholic Fatty Liver Disease (2014) (199)
- Non-alcoholic steatohepatitis: from cell biology to clinical practice. (2006) (198)
- Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis (2005) (197)
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients (2007) (192)
- Alcoholic liver disease: new insights into mechanisms and preventative strategies. (2001) (189)
- S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. (2012) (189)
- Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? (2002) (187)
- The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. (2008) (185)
- Polymerase γ Gene POLG determines the risk of sodium valproate‐induced liver toxicity (2010) (184)
- Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. (2007) (182)
- Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance (2008) (180)
- Candidate gene case-control association studies: advantages and potential pitfalls. (2001) (180)
- The natural history of histologically proved drug induced liver disease (1999) (178)
- Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease. (2016) (175)
- How big a problem is non-alcoholic fatty liver disease? (2011) (173)
- Genes or environment to determine alcoholic liver disease and non‐alcoholic fatty liver disease (2006) (170)
- Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease (2000) (164)
- A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. (2007) (163)
- Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. (2015) (160)
- Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease (2016) (159)
- Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. (2017) (157)
- Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD (2012) (156)
- Non-alcoholic fatty liver disease: current concepts and management strategies. (2006) (153)
- Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. (2007) (153)
- The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. (2012) (152)
- Pathogenesis of alcohol‐induced liver disease: Classical concepts and recent advances (2011) (152)
- Management strategies in alcoholic liver disease (2007) (150)
- Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol‐related end‐organ damage (1991) (149)
- Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease (2010) (149)
- Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. (2015) (148)
- Nonsteroidal anti-inflammatory drug-induced hepatotoxicity. (2007) (148)
- Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. (2002) (140)
- Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial (2017) (140)
- Genetic association studies in drug-induced liver injury. (2009) (135)
- The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2 (2015) (134)
- Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury. (2010) (133)
- AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease (2008) (129)
- Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. (2000) (128)
- Accuracy of hepatic adverse drug reaction reporting in one English health region (1999) (126)
- The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids (2007) (125)
- Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD (2016) (124)
- Non-alcoholic fatty liver disease: a massive problem. (2011) (119)
- Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance (1998) (119)
- Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. (2012) (118)
- PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease (2015) (117)
- Genetics of alcoholic and nonalcoholic fatty liver disease. (2011) (114)
- Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis (2020) (112)
- The management of alcoholic liver disease. (2003) (111)
- Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease (2013) (108)
- Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis. (2000) (105)
- Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. (2013) (104)
- Transplantation for alcoholic liver disease. (2002) (101)
- Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis (2001) (101)
- The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. (1998) (94)
- 379 Characteristics and Long-Term Prognosis of Lean Patients With Nonalcoholic Fatty Liver Disease (2014) (93)
- Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls (2014) (92)
- Detection and characterization of novel polymorphisms in the CYP2E1 gene. (1998) (91)
- Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. (2010) (90)
- Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease (2004) (89)
- Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels? (2013) (86)
- Other clinical studyThe natural history of nonalcoholic fatty liver: A follow-up study (1995) (84)
- Genetic and Environmental Susceptibility to Non-Alcoholic Fatty Liver Disease (2010) (84)
- Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease (1998) (83)
- Nonalcoholic fatty liver disease: new treatments (2015) (83)
- The biochemistry of alcohol-induced fatty liver. (1994) (82)
- A Methodological Approach to Tracing Cell Lineage in Human Epithelial Tissues (2009) (81)
- The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. (2011) (80)
- Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. (2007) (78)
- A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease (2009) (77)
- Gut Microbiota and Lifestyle Interventions in NAFLD (2016) (76)
- A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury. (2019) (75)
- Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease (2009) (72)
- Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease. (2014) (71)
- Genes and nonalcoholic fatty liver disease (2008) (69)
- Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis (2012) (69)
- Pain as a complication of use of opiate antagonists for symptom control in cholestasis. (2003) (67)
- Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial (2013) (65)
- Genetic modifiers of non-alcoholic fatty liver disease progression. (2011) (65)
- Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosis (1999) (64)
- Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease (2011) (63)
- Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. (2002) (63)
- TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? (2015) (61)
- A role for the pregnane X receptor in flucloxacillin‐induced liver injury (2010) (61)
- Who Gets Alcoholic Liver Disease: Nature or Nurture? (2000) (60)
- Glucokinase links Krüppel‐like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease (2012) (60)
- TM 6 SF 2 rs 58542926 Influences Hepatic Fibrosis Progression in Patients with Non-Alcoholic Fatty Liver Disease (2014) (59)
- Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease (2003) (59)
- Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes (2018) (59)
- Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease (2014) (59)
- Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver. (2010) (56)
- Genetic predisposition to alcoholic liver disease. (1992) (55)
- The potential role of genes in nonalcoholic fatty liver disease. (2004) (55)
- Warfarin dose requirement and CYP2C9 polymorphisms (1999) (54)
- N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group (2014) (52)
- Role of Polymorphisms in the Interleukin-10 Gene in Determining Disease Susceptibility and Phenotype in Inflamatory Bowel Disease (2001) (46)
- Genetic association studies in drug-induced liver injury (2012) (45)
- Functional Impairment in Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease Is Significant and Persists over 3 Years of Follow-Up (2013) (45)
- Inhibition of rat hepatocyte proliferation by transforming growth factor β and glucagon is associated with inhibition of ERK2 and p70 S6 kinase (1999) (45)
- Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease. (2014) (43)
- 127 HOMOZYGOSITY FOR THE PNPLA3/ADIPONUTRIN I148M POLYMORPHISM INFLUENCES LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (2010) (42)
- The European NAFLD registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. (2020) (42)
- Genetics of Alcoholic Liver Disease (2015) (42)
- A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. (2010) (41)
- Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitis. (2014) (40)
- Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control (2015) (40)
- A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis (2017) (39)
- The activity of the metabolic form of hepatic phosphatidate phosphohydrolase correlates with the severity of alcoholic fatty liver in human beings (1993) (38)
- Apoptosis in alcoholic hepatitis: a novel therapeutic target? (2001) (36)
- Nash-related liver failure: one hit too many? (2002) (36)
- The degree of hepatic steatosis associates with impaired cardiac and autonomic function. (2019) (35)
- White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers (2013) (33)
- Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. (2009) (33)
- Alcohol dehydrogenase polymorphisms and predisposition to alcoholic cirrhosis (1993) (33)
- Adverse physical effects of alcohol misuse (2008) (32)
- The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial. (2015) (32)
- Physical evidence for the presence of two forms of phosphatidate phosphohydrolase in rat liver. (1992) (32)
- Patatin‐like phospholipase domain containing 3: A case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease (2010) (31)
- Liver under Constant Attack — From Fat to Viruses (2009) (31)
- Clinical but not histological factors predict long‐term prognosis in patients with histologically advanced non‐decompensated alcoholic liver disease (2014) (30)
- Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation (2005) (29)
- No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis. (1998) (27)
- Brief Report: Genetics of Alcoholic Cirrhosis—GenomALC Multinational Study (2015) (27)
- The effect of gastritis on human gastric alcohol dehydrogenase activity and ethanol metabolism (1995) (27)
- Clinical Spectrum and Therapy of Non-Alcoholic Steatohepatitis (2012) (26)
- CYP2C9 polymorphism and warfarin dose requirements. (2002) (26)
- Resistance exercise improves autonomic regulation at rest and haemodynamic response to exercise in non-alcoholic fatty liver disease. (2013) (25)
- Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. (1999) (24)
- Genome‐wide Association Study and Meta‐analysis on Alcohol‐Associated Liver Cirrhosis Identifies Genetic Risk Factors (2020) (24)
- Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. (2021) (24)
- Treatment of alcoholic liver disease (2007) (24)
- The role of phosphatidic acid in platelet‐derived growth factor–induced proliferation of rat hepatic stellate cells (2000) (24)
- Is necroinflammation a prerequisite for fibrogenesis? (1996) (23)
- Valine‐alanine manganese superoxide dismutase polymorphism is not associated with alcohol‐induced oxidative stress or liver fibrosis (2002) (21)
- A trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis (2002) (21)
- Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance. (2015) (20)
- Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism. (1995) (20)
- Polymorphisms in Immunoregulatory Genes (2002) (19)
- Human liver stem cells originate from the canals of hering (2009) (18)
- A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. (2021) (18)
- A disease of emerging identity and importance (1998) (18)
- Risk of all-cause and cardiovascular mortality in patients with chronic liver disease (2010) (17)
- Relationship between the inhibition of phosphatidic acid phosphohydrolase-1 by oleate and oleoyl-CoA ester and its apparent translocation. (2005) (17)
- Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers. (2020) (16)
- Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity. (2011) (16)
- Non-Alcoholic Fatty Liver Disease: A Practical Guide (2013) (16)
- 7 The inheritance of alcoholic liver disease (1998) (16)
- Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease (2011) (16)
- How to Diagnose Nonalcoholic Fatty Liver Disease (2016) (15)
- Genetic studies to identify hepatic fibrosis genes and SNPs in human populations. (2005) (15)
- Comparison of the Glasgow Alcoholic Hepatitis Score and the ABIC Score for the Assessment of Alcoholic Hepatitis (2010) (14)
- CD14 promoter polymorphism associated with risk of NASH (2002) (14)
- Alcohol and the liver (2002) (14)
- Alcoholic liver disease: dose and threshold—new thoughts on an old topic (1997) (14)
- No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease. (2008) (13)
- Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis. (2018) (13)
- No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosis. (1992) (12)
- Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans (2016) (12)
- Liver Diseases in 2013: Advances in Pathogenesis and Treatment: Falk Symposium 191, London, October 2013 (2014) (12)
- Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease (2020) (12)
- 104 A CANDIDATE-GENE APPROACH TO VALIDATION OF GENETIC MODIFIER ASSOCIATIONS USING A LARGE COHORT WITH HISTOLOGICALLY CHARACTERISED NON-ALCOHOLIC FATTY LIVER DISEASE (2013) (12)
- Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: effects of platelet-derived growth factor and extracellular nucleotides. (2006) (12)
- Polymorphisms in immunoregulatory genes: towards individualized immunosuppressive therapy? (2002) (12)
- Orthostatic intolerance is common in chronic disease--a clinical cohort study. (2014) (11)
- British Association for the Study of the Liver (1991) (11)
- Genetic evidence for a role for gut flora in the pathogenesis of NASH in humans (2006) (10)
- Flucloxacillin-induced liver injury: the extended MHC 57.1 haplotype as a major risk factor (2008) (10)
- Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers (2017) (10)
- Manganese dependent superoxide dismutase (SOD2) targeting sequence polymorphism is associated with advanced fibrosis in patients with non-alcoholic fatty liver disease (2003) (10)
- Recombinant lysosomal acid lipase normalizes liver weight, transaminases and histopathological abnormalities in an in vivo model of cholesteryl ester storage disease (2011) (9)
- Current and future therapeutic strategies in NAFLD. (2010) (9)
- Regulation of phosphatidic acid phosphohydrolase 1 by fatty acids (2002) (9)
- Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment (2019) (9)
- Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance (2021) (9)
- The inheritance of alcoholic liver disease. (1998) (9)
- Falls and Fall-Related Injury Are Common in Older People with Chronic Liver Disease (2012) (9)
- Genetic variants of hepatic transporters and susceptibility to drug induced liver injury (2008) (9)
- Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome (2009) (8)
- European liver fibrosis (ELF) panel of serum markers can predict clinical outcome in a cohort of patients from England with mixed aetiology chronic liver disease (2007) (8)
- Genome-Wide Association Analysis Confirms Importance of PNPLA3 and Identifies Novel Variants Associated With Histologically Progressive Steatohepatitis in NAFLD (2012) (8)
- A coffee with your brandy, Sir? (2007) (8)
- The mitochondrial superoxide dismutase 2 (SOD2) targeting sequence polymorphism is associated with fibrotic NAFLD: Consistent evidence from case-control and intra-familial allelic association studies (2007) (7)
- No association between functional SNPS in the endotoxin receptors CD14 and TLR4 and alcoholic liver disease Is endotoxin important in the pathogenesis of ALD in humans (2001) (7)
- Variants in the LGALS9 Gene Are Associated With Development of Liver Disease in Heavy Consumers of Alcohol. (2016) (7)
- Transforming growth factor beta increases the activity of phosphatidate phosphohydrolase-1 in rat hepatocytes. (1997) (7)
- 900 RECOMBINANT LYSOSOMAL ACID LIPASE NORMALIZES LIVER WEIGHT, TRANSAMINASES AND HISTOPATHOLOGICAL ABNORMALITIES IN AN MODEL OF CHOLESTERYL ESTER STORAGE DISEASE (2011) (7)
- Sugar sweetened beverages and fatty liver disease: Rising concern and call to action. (2015) (7)
- TM6SF2 rs58542926 influences hepatic fibrosis (2015) (7)
- Erratum: 'Investigations of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end- organ damage' (Hepatology (1991) 14 (798-801)) (1992) (7)
- Plasma membrane form of phosphatidate phosphohydrolase: a possible role in signal transduction during liver fibrogenesis. (1993) (6)
- The genetic basis for non-alcoholic and alcoholic steatohepatitis. (2001) (6)
- 1275 CARRIAGE OF PNPLA3 I148M IS ASSOCIATED WITH AN INCREASED RISK OF NON-ALCOHOLIC FATTY LIVER DIESEASE ASSOCIATED HEPATOCELLULAR CARCINOMA (2013) (6)
- Nonalcoholic Fatty Liver Disease (2015) (6)
- A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'? (2012) (6)
- Susceptibility to drug induced liver injury determined by HLA class II genotype (2008) (6)
- WARFARIN DOSE REQUIREMENT AND CYP2C9 POLYMORPHISMS. AUTHORS' REPLY (1999) (5)
- Cognitive impairment in non-cirrhotic chronic liver disease is unrelated to liver disease severity but associated with ineffective baroreflex function (2011) (5)
- Genetic evidence supporting the two-hit model of NASH pathogenesis (2002) (5)
- Pure alcoholic fatty liver and progression to cirrhosis or fibrosis (1995) (5)
- Promoter polymorphisms of interleukin-10 (IL-10) and interleukin-4 (IL-4) predict the risk of diclofenac-induced hepatotoxicity (2000) (5)
- Heavy drinking greatly increases the risk of cirrhosis in patients with HCV hepatitis (2001) (4)
- Mitochondrial DNA does not contribute to the heritability of non-alcoholic fatty liver disease. (2011) (4)
- 844 RESISTANCE EXERCISE IMPROVES LIVER LIPID, FAT OXIDATION AND GLUCOSE CONTROL IN ADULTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE INDEPENDENT OF WEIGHT LOSS (2011) (4)
- 603 Correlation between anti-cyp2E1 titre and lymphocyte infiltration in ALD — an autoimmune disease in some patients? (2004) (4)
- Who gets alcoholic liver disease: nature or nurture? (extended abstract). (2003) (4)
- The genetic basis of hepatocellular cancer (2006) (4)
- 26 – Epidemiology, Natural History, and Evaluation of Nonalcoholic Fatty Liver Disease (2018) (4)
- ALCOHOLISM | Effects on Nutritional Status (1998) (3)
- 12. ALCOHOLIC LIVER DISEASE (2004) (3)
- Fatty liver disease is associated with both endotoxaemia and sub-clinical inflammation which is further aggravated by diabetes (2005) (3)
- Common POLG Genetic Variants Increase the Risk of Sodium Valproate Induced Liver Injury and Failure (2009) (3)
- Non-Alcoholic Fatty Liver Disease Non-Alcoholic Fatty Liver Disease (2013) (3)
- Predictive Value of Cytokine Polymorphisms for Liver Disease (2002) (3)
- Prevalence of auto-antibodies against cytochrome P4502E1 in alcoholic liver disease (2001) (3)
- Substantial variability of the diagnostic accuracy of serum fibrosis markers across multiple cohorts of nash patients in various centers : the case for the negative predictive value (2015) (3)
- Risk factors for alcohol‐related liver disease (2015) (2)
- TM6SF2 as a genetic risk factor for fibrosis (2015) (2)
- Chapter 29 – Alcoholic Liver Disease (2006) (2)
- A randomised controlled trial of calcineurin inhibitor (CNI) replacement with mycophenolate mofetil and steroids in liver transplant patients with renal dysfunction (2004) (2)
- Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515). (2021) (2)
- Nash is A Genetically Determined Disease (2007) (2)
- High intensity intermittent training improves cardiac function and reduces liver fat in adults with Type 2 diabetes: an MRI/S study (2015) (2)
- Researchendotoxin levels in non-alcoholic fatty liver disease (2010) (2)
- Genetic evidence that fatty liver is involved in the pathogenesis of advanced alcoholic liver disease (2002) (2)
- Genetic variation in TM 6 SF 2 and the risk of nonalcoholic fatty liver disease and histological disease severity " by Sookoian (2014) (2)
- An algorithm combining direct and indirect liver fibrosis tests enhances diagnostic performance for the detection of advanced fibrosis (F3-4) in NAFLD minimising the need for liver biopsy (2012) (2)
- Corrigendum: PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease (2015) (2)
- Cognitive Symptoms and Prevalent in Non-Alcoholic Fatty Liver Disease (NAFLD) and Unrelated to the Severity of Liver Disease (2009) (2)
- Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis (1999) (2)
- PTH-090 Natural History Of Nafld: A Study Of 108 Patients With Paired Liver Biopsies (2014) (2)
- Increased susceptibility to alcoholic liver disease in females is not due to either higher blood alcohol concentrations or lower first pass metabolism (1995) (2)
- HFE AND ALCOHOLIC LIVER DISEASE. AUTHOR'S REPLY (1999) (1)
- Association of udp-glucuronosyltransferase (UGT) 2B7 genotype with diclofenac-induced hepatotoxicity (2002) (1)
- Can genetic influence in non‐alcoholic fatty liver disease be ignored? (2016) (1)
- 80 The glasgow alcoholic hepatitis score identifies patients likely to benefit from corticosteroids (2004) (1)
- Appreciation of the benefits of exercise programmes in non-alcoholic liver disease: implications of fatigue and impact upon activities of daily living (2008) (1)
- Steatosis and Inflammation are Together Associated with Fibrosis Progression in Patients with NASH (2009) (1)
- Obstructive sleep apnoea is common in adults with biopsy-proven non-alcoholic fatty liver disease. (2015) (1)
- Poster sessionsPrevalence of auto-antibodies against cytochrome P4502E1 in alcoholic liver disease (2001) (1)
- Intravenous bisphosphonate pre liver transplant prevents osteoporotic vertebral collapse (1996) (1)
- EditorialNash-related liver failure: one hit too many? (2002) (1)
- Liver disorder and the HFE locus. (2001) (1)
- PWE-285 Clinical but not histological factors predict long-term prognosis in patients with biopsy proven advanced alcoholic liver disease (2012) (1)
- 72 MAPPING EXPRESSION QUANTITATIVE TRAITS LOCI (eQTL) FOR PNPLA3 GENE IDENTIFIES ADDITIONAL SNPS ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) INDEPENDENT OF rs738409 (2013) (1)
- Erratum: PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease (Am J Gastroenterol 110:846-856(2015) DOI: 10.1038/ajg.2015.137) (2015) (1)
- Alpha-1-antitrypsin genotype — A risk factor for alcoholic cirrhosis? (1991) (1)
- Resistance exercise improves liver fat and glucose control in people with non-alcoholic fatty liver disease (2011) (1)
- Stimulation of phosphatidate phosphohydrolase by T6F$beta; in hepatocytes: A possible mechanism for the antiproliferative effects? (1993) (1)
- Relevance of PXR to Flucloxacillin-induced Liver Injury (2008) (1)
- POLG determines the risk of sodium valproate induced liver toxicity (2013) (1)
- A 'loss-of-function' mutation in TIRAP, the gene encoding the Toll-like receptor adapter molecule MAL protects against fibrosis in NAFLD but not ALD (2008) (1)
- Recurrent noctural hypoxaemia is associated with progressive non-alcoholic fatty liver disease (NAFLD) (2008) (1)
- O043 : The FNDC5 rs3480 is protective on the steatosis and fibrosis in patients with NAFLD (2015) (1)
- Polymorphism in the interleukin (IL-10) gene in patients with inflammatory bowel disease (1998) (1)
- The ADAMs: A modular protein family with metalloproteinase and proteoglycan degrading activities expressed by the hepatic stellate cell (2001) (1)
- Grading alcoholic hepatitis (2005) (1)
- 720 Oxidative stress is an independent risk factor for the progression of non-alcoholic fatty liver disease (NAFLD) to advanced fibrosis (2003) (1)
- What is Non‐Alcoholic Fatty Liver Disease (NAFLD), and Why is it Important? (2013) (1)
- 1362 CLINICAL BUT NOT HISTOLOGICAL FACTORS PREDICT LONG-TERM PROGNOSIS IN PATIENTS WITH BIOPSY PROVEN ADVANCED ALCOHOLIC LIVER DISEASE (2012) (1)
- P87 Vascular Adhesion Protein-1 promotes increases in liver infiltrating CD4+ T cells and NKT cells and induction of fibrogenesis in steatohepatitis (2011) (1)
- 82 KRUPPEL LIKE FACTOR 6 (KLF6) REGULATES HEAPTIC INSULIN RESISTANCE (HEP-IR) (2010) (1)
- 1369 HIGH-INTENSITY INTERMITTENT EXERCISE THERAPY REDUCES LIVER FAT AND IMPROVES BODY COMPOSITION IN ADULTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (2013) (1)
- Alcohol—Risks and Mechanisms of Damage (1994) (1)
- Polymorphism in the interleukin-10 (IL-10) promoter is associated with fibrotic alcoholic liver disease (1998) (1)
- Ethanol Metabolism and Pathogenesis of Alcoholic Liver Injury (2008) (1)
- GUTJNL216077-225110 1265..1269 (0)
- NON-ALCOHOLIC STEATOHEPATITIS. AUTHORS' REPLY (1999) (0)
- Non-alcoholic steatohepatitis — therapeutic interventions (2009) (0)
- Treatment of NAFLD (2014) (0)
- Long-term orlistat treatment reduces endotoxinaemia in fatty liver disease patients (2007) (0)
- ResearchElevated endotoxin levels in non-alcoholic fatty liver disease (2015) (0)
- CTLA-4 gene polymorphisms are associated with acute rejection after liver transplantation (2005) (0)
- Diet, Physical Activity, Sedentary Behaviour and Sleep in 1289 Adults with Liver Disease; A Cross Sectional Study of Data from the UK Biobank (2016) (0)
- F.N.39 HOMOZYGOSITY FOR THE PNPLA3/ADIPONUTRIN I148M POLYMORPHISM INFLUENCES LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (2010) (0)
- Polymorphisms in the T-cell regulatory gene CTLA-4 are associated with susceptibility for acute rejection after liver transplantation (2006) (0)
- 29. Non-Alcoholic Fatty Liver Disease (2010) (0)
- Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆" [J Hepatol (2020) 505-515]. (2023) (0)
- Evidence that alcoholic liver disease is due to immune mechanisms in genetically susceptible drinkers (2002) (0)
- The burden of alcoholic liver disease (ALD) on a regional referral centre (2001) (0)
- Subject Index Vol. 55, 2009 (2009) (0)
- Failure of biliary excretion leads to accumulation of digoxin-like immunoreactive subtances in liver disease (1992) (0)
- Non-Alcohlic Fatty Liver Disease is Associated with Recurrent Falls and Significant Injury (2009) (0)
- Exercise Therapy in Patients Consuming Moderate Alcohol: A Randomised Control Trial (2016) (0)
- BCMO1 deficiency induces nonalcoholic steatohepatitis independent of fatty acid oxidation and synthesis (2011) (0)
- Genetic susceptibility to alcoholic liver disease (2004) (0)
- Fatigue in NAFLD is severe and associates with excessive daytime somnolence but not with liver disease severity or insulin resistance (2007) (0)
- Regulation of human phosphatidate phosphohydrolase in human liver (1991) (0)
- Physical activity levels are lower in people with non-alcoholic fatty liver disease than matched healthy controls (2012) (0)
- Liver Disease in Obesity (2009) (0)
- 1290 SULFATASE-2 (SULF2) EXPRESSED IN HEPATOCYTES AND STROMAL CELLS CONTRIBUTES TO THE DEVELOPMENT OF STEATOSIS, THE PROGRESSION OF NAFLD TO FIBROSIS AND THE ADVANCEMENT OF CANCER (2013) (0)
- Genetic Factors in the Pathogenesis of Drug-Induced Liver Injury (2013) (0)
- Non-Alcoholic Fatty Liver Disease (2018) (0)
- Monotherapy with mycophenolate mofetil (MMF): Good for the kidneys badfor the liver (2000) (0)
- European liver fibrosis panel of serum markers can predict serious fibrosis on biopsy and clinical outcome in patients with mixed aetiology chronic liver disease (2008) (0)
- Identification of phospholipase D gene products in activated rat hepatic stellate cells - Stimulation by PDGF and nucleotides (2001) (0)
- Subject Index Vol. 30, Suppl. 1, 2012 (2012) (0)
- Comprar Liver Under Constant Attack - From Fat to Viruses | Day, C.P. | 9789048127580 | Springer (2009) (0)
- 1 GENETIC VARIATION IN LGALS 9 CONFERS SUSCEPTIBILITY TO ALCOHOLIC LIVER DISEASE (2016) (0)
- Iron content of alcoholic fatty liver does not predict progression to fibrotic disease (1998) (0)
- [704] MITOCHONDRIAL DNA HAPLOGROUPS ASSOCIATED WITH HISTOLOGICAL SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) (2007) (0)
- PWE-286 Direct serum markers are more accurate than simple marker panels for the detection of fibrosis in non-alcoholic fatty liver disease (NAFLD) (2012) (0)
- Endothelin induced activation of hepatic stellate cells is via JNK and p38 map kinases (1998) (0)
- University of Dundee Association of Liver Injury From Specific Drugs , or Groups of Drugs , With Polymorphisms in HLA and Other Genes in a Genome-wide Association Study (0)
- Claudin 10 (CLDN10) - a Candidate Suceptibility Gene for NAFLD Progression (2009) (0)
- 1076 A “loss-of-function” polymorphism in ICAM-1 protects heavy drinkers from alcoholic liver disease (2003) (0)
- Neo-antigen specific T-cell responses are closely associated with the presence of liver disease in heavy drinkers (2002) (0)
- Relationship of UGT2B7 genotype with diclofenac hepatotoxicity (2003) (0)
- 1282 MILD STEATOSIS AND IMPAIRED GLUCOSE TOLERANCE ARE ASSOCIATED WITH LIVER CANCER DEVELOPMENT, WHILE PROGRESSION TO NASH INCREASES NUMBER/SIZE IN AN ANIMAL MODEL OF NAFLD (2013) (0)
- Sensitivity analysis of the primary outcome (2015) (0)
- liver disease clinical outcomes in patients with chronic Enhanced liver fibrosis test can predict and (0)
- Genetic Polymorphisms of Galectin-9 (Gal-9) Associated with Risk of Developing Alcoholic Liver Disease (ALD) in Humans (2013) (0)
- Bile acids have a direct effect on collagen biosynthesis by hepatic stellate cells (2002) (0)
- European liver fibrosis markers can predict clinical outcome in patients with chronic liver disease (2008) (0)
- Liver: Can pentoxifylline secure its place in liver therapeutics? (2010) (0)
- 58 THE KRUPPEL-LIKE FACTOR 6 (KLF6) GENOTYPE WHICH IS ASSOCIATED WITH NAFLD PROGRESSION IS ASSOCIATED WITH HIGHER FASTING SERUM GLUCOSE LEVELS IN HEALTHY INDIVIDUALS (2009) (0)
- Genetic evidence that lipid trafficking plays a key role in fibrosis in non alcoholic fatty liver disease (2007) (0)
- Autonomic function is impaired across the spectrum of NAFLD (2017) (0)
- Immunology and Liver Disease / Liver and Metabolic Syndrome: Immunology and Liver Disease Falk Workshop 2009, Hannover, October 2009 / Liver and Metabolic Syndrome Falk Symposium 171, Hannover, October 2009 (2010) (0)
- Cost-Effectiveness of Diagnostic Tests for People At Risk of Non-Alcoholic Fatty Liver Disease (NAFLD) in The UK (2016) (0)
- European liver fibrosis (ELF) markers accurately distinguish fibrosis severity in non alcoholic fatty liver disease (NAFLD); An external validation study (2006) (0)
- Extrahepatic effects of alcohol: an overview (2002) (0)
- Integrin receptor expression changes in diseased hepatic stellate cells (2001) (0)
- Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease (2012) (0)
- [22] THE KLF6 (IVS1-27G > A) POLYMORPHISM IS ASSOCIATED WITH NON-PROGRESSIVE NAFLD (2007) (0)
- O065 : Mechanistic study of TM6SF2 in NAFLD pathogenesis: Stably transfected Huh7 cells over-expressing the TM6SF2 E167K variant exhibit greater levels of oxidative stress (2015) (0)
- P1043 : Exercise reduces liver fat, visceral fat and circulating triglycerides, but not circulating inflammatory markers in non-alcoholic steatohepatitis (2015) (0)
- Dataset Supplementing The Article A Randomised Controlled Trial Of Losartan As An Anti-Fibrotic Agent In Non-Alcoholic Steatohepatitis (2017) (0)
- 1076 DIRECT SERUM MARKERS ARE MORE ACCURATE THAN SIMPLE MARKER PANELS FOR THE DETECTION OF FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) (2012) (0)
- [699] DIFFERENTIAL EXPRESSION OF GSTT1 AND GSTT2 IS ASSOCIATED WITH MORE ADVANCED FIBROSIS IN PATIENTS WITH NAFLD (2007) (0)
- P09 Validation of a novel biomarker model for the prediction of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease (2011) (0)
- Pain as a complication of opiate antagonist therapy in cholestasis: A single centre experience (2002) (0)
- Regulation of ADAMS family members in hepatic stellate cells by soluble growth factors: Evidence for their role in hepatic fibrogenesis (2001) (0)
- VALIDATION OF A NOVEL BIOMARKER MODEL FOR THE PREDICTION OF NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (2011) (0)
- Corrigendum to: 'A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers' [J Hepatol 2022 (76) 275-282]. (2022) (0)
- 1337 CARDIAC FUNCTION IMPROVES FOLLOWING HIGH INTENSITY INTERMITTENT EXERCISE THERAPY IN NON-ALCOHOLIC FATTY LIVER DISEASE (2013) (0)
- Unit cost: intervention, initial admission and adverse events costs (2015) (0)
- Liver fat independently associates with impaired cardiac and autonomic function (2019) (0)
- Enhanced liver fibrosis (ELF) score predicts clinical outcome in patients with chronic liver disease (2008) (0)
- 1338 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH HIGHER OBJECTIVELY MEASURED SEDENTARY BEHAVIOUR AND LOWER LEVELS OF PHYSICAL ACTIVITY THAN MATCHED HEALTHY CONTROLS (2013) (0)
- A polymorphism in CTLA-4 is associated with the presence of anti-CYP2E1 antibody titres in patients with alcoholic liver disease (2001) (0)
- Fatigue in non-alcoholic fatty liver disease: is there a role for hypothyroidism Response (2009) (0)
- Unsupervised high-intensity intermittent training reduces liver fat and improves body composition in adults with non-alcoholic fatty liver disease (NAFLD) (2013) (0)
- Terlipressin for hepatorenal impairment in alcoholic hepatitis (2000) (0)
- Allo- and auto-antibody responses in ALD as biomarkers of prognosis (2010) (0)
- Promoter polymorphisms of IL-10 and IL-4 predict risk ofdiclofenac-induced hepatitis (2000) (0)
- 1001 CYTOCHOME P450 2E1 (CYP2E1) AUTOREACTIVITY IN ALCOHOLIC LIVER DISEASE: NO EVIDENCE FOR A PATHOGENETIC ROLE (2009) (0)
- Mitochondrial DNA haplogrouping in non alcoholic fatty liver disease (NAFLD) (2006) (0)
- Health-economic evaluation (2016) (0)
- Subject Index Vol. 34, Suppl. 1, 2016 (2016) (0)
- TNF and HLA DR8 Polymorphisms in Primary Biliary Cirrhosis: Genetic Control of Disease Progression? (1998) (0)
- OPINION Nonalcoholic fatty liver disease: new treatments (2015) (0)
- Polymorphisms of immunoregulatory genes: A step towards individually tailored immunosuppression? (2001) (0)
- Interleukin-10 -592 promoter polymorphism and primary biliary cirrhosis: No association with disease susceptibility or severity (1998) (0)
- A polymorphism in interleukin-4 is associated with Crohn's disease (2000) (0)
- Genetic Predisposition to NAFLD and NASH: Implications for Pathogenesis, Diagnosis, Prevention, and Management (2013) (0)
- 1308 THE FIB-4 SCORE RELIABLY EXCLUDES ADVANCED FIBROSIS IN A DIABETIC COHORT WITH NAFLD (2012) (0)
- Chapter 28 – Alcoholic Liver Disease (2012) (0)
- P13 Allo- and auto-antibody responses in alcoholic liver disease as biomarkers of prognosis (2010) (0)
- Title : Association of Liver Injury From Specific Drugs , or Groups of Drugs , With Polymorphisms in HLA and Other Genes in a Genome-wide Association Study (2016) (0)
- P0271 : Effects of FXR agonist PX20606 on tumour formation in animal models of non-alcoholic fatty liver disease (2015) (0)
- Contents Index Vol. 55, 2009 (2009) (0)
- Digoxin-like factors in liver disease. (1989) (0)
- 73 KR ÜPPEL LIKE FACTOR 6 (KLF6) PROTECTS FROM NAFLD PROGRESSION THROUGH REGULATION OF ADIPOSE TISSUE INSULIN RESISTANCE (2013) (0)
- Warfarin induced cholestatic jaundice in a patient receiving total parenteral nutrition (2008) (0)
- Average adverse event investigations per treatment arm (2015) (0)
- Nucleotides stimulate phospholipasc D activity in hepatic stellate cells: evidence for the involvement of a single nucleotide receptor, protein kinase C and a pertussis toxin insensitive guanine-nucleotide binding protein (2000) (0)
- N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group (2014) (0)
- Role of oxidative stress in promoting immune reactions associated with alcoholic liver disease (2004) (0)
- Circulating visfatin levels reduced in patients with non-alcoholic fatty liver disease irrespective of type 2 diabetes mellitus status (2009) (0)
- Mo1001 Prognostic Relevance of Serum Ferritin in Patients With Nonalcoholic Fatty Liver Disease (2013) (0)
- [719] EFFECTS OF ETHANOL ON ENDOTOXIN-MEDIATED CYTOKINE RELEASE: SENSITISATION VIA TLR4 BUT NORMAL TOLERANCE (2007) (0)
- Anti-cytochrome P4502E1 autoantibody titre associates with immune liver histology in advanced alcoholic liver disease (2004) (0)
- Ethanol-induced histone acetylation: A novel mechanism for enhancement of inflammation in alcoholic hepatitis? (2007) (0)
- Susceptibility to alcoholic liver disease is determined by genetically determined differences in the immune response to acetaldehyde adducts (2000) (0)
- Mitogenic Signal Transduction Pathways Involved in Hepatic Stellate Cells (1996) (0)
- A common polymorphism in the ABCB11 gene encoding for the bile salt export pump is associated with advanced fibrosis in hepatitis C infection but not in fatty liver disease (2010) (0)
- Non-alcoholic steatohepatitis: metabolic syndrome of the liver (2008) (0)
- British Association for the Study of the Liver Meeting (2000) (0)
- Prognostic score formula (2015) (0)
- 1308 A ROLE FOR DNA REPAIR PROTEIN KINASE (DNA-PK) IN THE PROGRESSION OF SIMPLE STEATOSIS TO STEATOHEPATITIS (NASH)? (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Christopher Paul Day?
Christopher Paul Day is affiliated with the following schools: